what increases glp 1 levels GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Agonists - What is

The increasing use of GLP-1s, along with the recently issued coverage guidance by the CMS, will present several important factors for plans to consider in the future

After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025

Severe cramping, extreme nausea, or dizziness warrants prompt contact

Integrated approach to weight management combines medication with nutritional guidance, lifestyle coaching, and support for sustainable results

GLP-1 medications have gained attention for their role in managing type 2 diabetes and supporting weight loss when prescribed by a healthcare professional